Impact of a Biophoton Therapy on Patients With Brain Disorders

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About 80 patients with brain disorder (Alzheimer's disease, dementia, stroke, traumatic brain injury, Parkinson's disease) will participate in the intervention clinical study at the Tesla MedBed Center located in Butler, PA.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Must meet conditions for approval.

• Must be 18-years or older and stay in a hotel.

• Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.

• Can provide informed consent or can be assisted by caregiver.

• Can provide a clinical diagnosis of a brain disorder.

• Can complete all study procedures during the study.

• Must be fluent in English (or the Caregiver can fully translate).

• Women of childbearing age must provide results of a pregnancy test in order to participate.

Locations
United States
Pennsylvania
Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001
RECRUITING
Butler
Time Frame
Start Date: 2023-11-08
Estimated Completion Date: 2026-11-08
Participants
Target number of participants: 80
Treatments
Experimental: Treatment Group
The 14 active Biophoton Generators packed with the same 32-Oz metal can will be labeled with a code and placed under a hotel bed. Each participant will rest on the bed during the entire study period for 4 weeks. Participants will receive biophotons inside of the biophoton field generated by 14 active Biophoton Generators
Placebo_comparator: Control Group
The 14 inactive Biophoton Generators packed with the same 32-Oz metal can will be labeled with a code and placed under a hotel bed. Each participant will rest on the bed during the entire study period for the first 2 weeks. Then will be switched to the active treatment group for being treated for 4 weeks. Participants will receive placebo effect from the 14 inactive comparators.
Related Therapeutic Areas
Movement Disorders
Stroke
Parkinson's Disease
Alzheimer's Disease
Dementia
Sponsors
Leads: First Institute of All Medicines

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

Pilot Trial of a Web/Mobile/Tablet-based Communication and Goals-of-Care Decision Aid for Clinicians and Families of Severe Acute Brain Injury Patients

Pilot Trial of a Web/Mobile/Tablet-based Communication and Goals-of-Care Decision Aid for Clinicians and Families of Severe Acute Brain Injury Patients

Enrollment Status: Recruiting
Publish Date: September 23, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable

Prospective Neuroimaging, Cognition and Behavioural Study of Alzheimer's, Vascular, Parkinson's, Frontotemporal and Mixed Dementias

Prospective Neuroimaging, Cognition and Behavioural Study of Alzheimer's, Vascular, Parkinson's, Frontotemporal and Mixed Dementias

Enrollment Status: Recruiting
Publish Date: January 31, 2025

Research on the Early and Prognosis Diagnosis of Vascular Dementia

Research on the Early and Prognosis Diagnosis of Vascular Dementia

Enrollment Status: Recruiting
Publish Date: May 15, 2017
View All